ReviewFrontiers in immunology2025

Synergy of oncolytic adenovirus and immune checkpoint inhibitors: transforming cancer immunotherapy paradigms.

Chong Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.